188 related articles for article (PubMed ID: 24259986)
1. Prognostic factors associated with solitary plasmacytoma.
Guo SQ; Zhang L; Wang YF; Sun BC; Zhang LY; Zhang J; Wang G; Zhang YZ
Onco Targets Ther; 2013; 6():1659-66. PubMed ID: 24259986
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
Nakaya A; Tanaka H; Yagi H; Ohta K; Shibayama H; Kohara T; Kanda J; Shindo M; Shimura Y; Kosugi S; Kida T; Kaneko H; Imada K; Karasuno T; Matsuda M; Iida M; Adachi Y; Fuchida SI; Uoshima N; Uchiyama H; Takahashi R; Matsui T; Wada K; Kiyota M; Shimazaki C; Hino M; Kuroda J; Kanakura Y; Takaori-Kondo A; Nomura S; Matsumura I;
Int J Hematol; 2020 Nov; 112(5):666-673. PubMed ID: 32783165
[TBL] [Abstract][Full Text] [Related]
3. Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone.
Shih LY; Dunn P; Leung WM; Chen WJ; Wang PN
Br J Cancer; 1995 Jan; 71(1):128-33. PubMed ID: 7819027
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors.
Suh YG; Suh CO; Kim JS; Kim SJ; Pyun HO; Cho J
Ann Hematol; 2012 Nov; 91(11):1785-93. PubMed ID: 22752147
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy in the treatment of solitary plasmacytoma.
Jyothirmayi R; Gangadharan VP; Nair MK; Rajan B
Br J Radiol; 1997 May; 70(833):511-6. PubMed ID: 9227234
[TBL] [Abstract][Full Text] [Related]
6. Clinical course of solitary extramedullary plasmacytoma.
Liebross RH; Ha CS; Cox JD; Weber D; Delasalle K; Alexanian R
Radiother Oncol; 1999 Sep; 52(3):245-9. PubMed ID: 10580871
[TBL] [Abstract][Full Text] [Related]
7. Clinical features, therapy patterns, outcomes and prognostic factors of solitary plasmacytomas: a report of the Israeli Myeloma Study Group.
Ganzel C; Trestman S; Levi S; Gatt ME; Lavi N; Vaxman I; Rouvio O; Magen H; Lebel E; Horowitz NA; Leiba M; Tadmor T; Herzog Tzarfati K; Surio C; Yeganeh S; Dally N; Avivi I; Cohen YC
Leuk Lymphoma; 2022 Dec; 63(14):3448-3455. PubMed ID: 36075048
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and prognostic factors in solitary plasmacytoma.
Finsinger P; Grammatico S; Chisini M; Piciocchi A; Foà R; Petrucci MT
Br J Haematol; 2016 Feb; 172(4):554-60. PubMed ID: 26684545
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 years.
Barzenje DA; Kolstad A; Ghanima W; Holte H
Hematol Oncol; 2018 Feb; 36(1):217-223. PubMed ID: 28393375
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation and outcomes of solitary plasmacytoma in a tertiary hospital in the UK.
Agbuduwe C; Yang H; Gaglani J; Ajithkumar T
Clin Med (Lond); 2020 Sep; 20(5):e191-e195. PubMed ID: 32934063
[TBL] [Abstract][Full Text] [Related]
11. Effect of definitive radiotherapy on the long-term outcome in patients with solitary extramedullary plasmacytoma.
Skóra T; Pudełek K; Nowak-Sadzikowska J; Pietrasz M; Szyszka-Charewicz B; Jakubowicz J
Hematol Oncol; 2017 Sep; 35(3):317-322. PubMed ID: 26450521
[TBL] [Abstract][Full Text] [Related]
12. Solitary plasmacytoma: 10 years' experience at All India Institute of Medical Sciences, New Delhi.
Baghmar S; Mohanti BK; Sharma A; Kumar L; Prakash G; Kumar S; Gupta R; Kumar R; Raina V
Leuk Lymphoma; 2013 Aug; 54(8):1665-70. PubMed ID: 23163525
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study of correlation of morphologic patterns, MIB1 proliferation index, and survival analysis in 134 cases of plasmacytoma.
Ghodke K; Shet T; Epari S; Sengar M; Menon H; Gujral S
Ann Diagn Pathol; 2015 Jun; 19(3):117-23. PubMed ID: 25842207
[TBL] [Abstract][Full Text] [Related]
14. Solitary plasmacytoma of bone and soft tissue.
Bolek TW; Marcus RB; Mendenhall NP
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):329-33. PubMed ID: 8892456
[TBL] [Abstract][Full Text] [Related]
15. A review for solitary plasmacytoma of bone and extramedullary plasmacytoma.
Kilciksiz S; Karakoyun-Celik O; Agaoglu FY; Haydaroglu A
ScientificWorldJournal; 2012; 2012():895765. PubMed ID: 22654647
[TBL] [Abstract][Full Text] [Related]
16. Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.
Katodritou E; Terpos E; Symeonidis AS; Pouli A; Kelaidi C; Kyrtsonis MC; Kotsopoulou M; Delimpasi S; Christoforidou A; Giannakoulas N; Viniou NA; Stefanoudaki E; Hadjiaggelidou C; Christoulas D; Verrou E; Gastari V; Papadaki S; Polychronidou G; Papadopoulou A; Giannopoulou E; Kastritis E; Kouraklis A; Konstantinidou P; Anagnostopoulos A; Zervas K; Dimopoulos MA
Am J Hematol; 2014 Aug; 89(8):803-8. PubMed ID: 24757085
[TBL] [Abstract][Full Text] [Related]
17. Solitary Extramedullary Plasmacytoma Presenting as Asymptomatic Palatal Erythroplakia: Report of a Case.
Lalla F; Vinciguerra A; Lissoni A; Arrigoni G; Lira Luce F; Abati S
Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33916539
[TBL] [Abstract][Full Text] [Related]
18. Maximizing the Clinical Benefit of Radiotherapy in Solitary Plasmacytoma: An International Multicenter Analysis.
Elsayad K; Oertel M; König L; Hüske S; Le Ray E; Meheissen MAM; Elsaid AA; Elfaham E; Debus J; Kirova Y; Herfarth K; Eich HT
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183106
[No Abstract] [Full Text] [Related]
19. Radiotherapy of solitary plasmacytoma.
Krause S; Hillengass J; Goldschmidt H; Debus J; Neuhof D
Ann Hematol; 2011 Sep; 90(9):1093-7. PubMed ID: 21336625
[TBL] [Abstract][Full Text] [Related]
20. Clinical course and survival in 16 patients with localized plasmacytoma.
Wollersheim HC; Holdrinet RS; Haanen C
Scand J Haematol; 1984 Apr; 32(4):423-8. PubMed ID: 6719045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
